{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE213nnn/GSE213809/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Transcriptomics"],"species":["Homo sapiens"],"gds_type":["Expression profiling by high throughput sequencing"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE213809"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"Comparative study in gene expression of type 2 cytokine secretion activity of Group 2 innate lymphoid cells (ILC2s) isolated from nasal polyps or peripheral blood of patients with chronic eosinophilic rhinosinusitis with nasal polyps","description":"To investigate the differences in type 2 cytokine secretion activity of ILC2s by original location in vivo, we performed time series measurements of type 2 cytokine secretion activity of ILC2 after IL-33 stimulation on ILC2 isolated from peripheral blood or nasal polyps sampled from patients with with chronic eosinophilic rhinosinusitis. Secretion-negative or -positive cells after stimulation were collected separately and performed RNA-seq on each cell for gene expression profiling analysis.","dates":{"publication":"2026/09/20"},"accession":"GSE213809","cross_references":{"GSM":["GSM6595651","GSM6595673","GSM6595674","GSM6595652","GSM6595671","GSM6595672","GSM6595650","GSM6595670","GSM6595659","GSM6595657","GSM6595658","GSM6595655","GSM6595656","GSM6595675","GSM6595653","GSM6595654","GSM6595662","GSM6595663","GSM6595660","GSM6595661","GSM6595648","GSM6595649","GSM6595668","GSM6595646","GSM6595669","GSM6595647","GSM6595666","GSM6595644","GSM6595645","GSM6595667","GSM6595664","GSM6595665"],"GPL":["15520"],"GSE":["213809"],"taxon":["Homo sapiens"]}}